Cargando…

Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis

BACKGROUND: Adenoid cystic carcinoma (AdCC) of the head and neck is an uncommon malignant epithelial tumour of the secretory glands. Many patients develop slowly growing local recurrence and/or distant metastasis, for which treatment options are limited. A retrospective analysis of 9 AdCC patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Klein Nulent, Thomas J. W., van Es, Robert J. J., Krijger, Gerard C., de Bree, Remco, Willems, Stefan M., de Keizer, Bart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537328/
https://www.ncbi.nlm.nih.gov/pubmed/28593386
http://dx.doi.org/10.1007/s00259-017-3737-x
_version_ 1783254152779923456
author Klein Nulent, Thomas J. W.
van Es, Robert J. J.
Krijger, Gerard C.
de Bree, Remco
Willems, Stefan M.
de Keizer, Bart
author_facet Klein Nulent, Thomas J. W.
van Es, Robert J. J.
Krijger, Gerard C.
de Bree, Remco
Willems, Stefan M.
de Keizer, Bart
author_sort Klein Nulent, Thomas J. W.
collection PubMed
description BACKGROUND: Adenoid cystic carcinoma (AdCC) of the head and neck is an uncommon malignant epithelial tumour of the secretory glands. Many patients develop slowly growing local recurrence and/or distant metastasis, for which treatment options are limited. A retrospective analysis of 9 AdCC patients was conducted to analyse the visualization of AdCC on PSMA PET/CT and to investigate the expression of PSMA on primary, recurrent and metastatic AdCC tumour tissue using immunohistochemistry. RESULTS: Local recurrence occurred in six patients and eight developed distant metastasis. All PET/CTs depicted PSMA-ligand uptake. Four PSMA PET/CTs showed suspected residual disease, eight scans depicted uptake in areas suspected of distant metastasis. Median Maximum Standardized Uptake Value (SUV(max)) in local recurrent and distant metastatic AdCC was 2.52 (IQR 2.41–5.95) and 4.01 (IQR 2.66–8.71), respectively. All primary tumours showed PSMA expression on immunohistochemistry (5–90% expression), as well as all available specimens of local recurrence and distant metastases. CONCLUSION: PSMA PET/CT is able to detect and visualize local recurrent and distant metastatic AdCC. PSMA-specific targeting is supported by PSMA expression on immunohistochemistry.
format Online
Article
Text
id pubmed-5537328
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-55373282017-08-15 Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis Klein Nulent, Thomas J. W. van Es, Robert J. J. Krijger, Gerard C. de Bree, Remco Willems, Stefan M. de Keizer, Bart Eur J Nucl Med Mol Imaging Original Article BACKGROUND: Adenoid cystic carcinoma (AdCC) of the head and neck is an uncommon malignant epithelial tumour of the secretory glands. Many patients develop slowly growing local recurrence and/or distant metastasis, for which treatment options are limited. A retrospective analysis of 9 AdCC patients was conducted to analyse the visualization of AdCC on PSMA PET/CT and to investigate the expression of PSMA on primary, recurrent and metastatic AdCC tumour tissue using immunohistochemistry. RESULTS: Local recurrence occurred in six patients and eight developed distant metastasis. All PET/CTs depicted PSMA-ligand uptake. Four PSMA PET/CTs showed suspected residual disease, eight scans depicted uptake in areas suspected of distant metastasis. Median Maximum Standardized Uptake Value (SUV(max)) in local recurrent and distant metastatic AdCC was 2.52 (IQR 2.41–5.95) and 4.01 (IQR 2.66–8.71), respectively. All primary tumours showed PSMA expression on immunohistochemistry (5–90% expression), as well as all available specimens of local recurrence and distant metastases. CONCLUSION: PSMA PET/CT is able to detect and visualize local recurrent and distant metastatic AdCC. PSMA-specific targeting is supported by PSMA expression on immunohistochemistry. Springer Berlin Heidelberg 2017-06-07 2017 /pmc/articles/PMC5537328/ /pubmed/28593386 http://dx.doi.org/10.1007/s00259-017-3737-x Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Klein Nulent, Thomas J. W.
van Es, Robert J. J.
Krijger, Gerard C.
de Bree, Remco
Willems, Stefan M.
de Keizer, Bart
Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis
title Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis
title_full Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis
title_fullStr Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis
title_full_unstemmed Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis
title_short Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis
title_sort prostate-specific membrane antigen pet imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537328/
https://www.ncbi.nlm.nih.gov/pubmed/28593386
http://dx.doi.org/10.1007/s00259-017-3737-x
work_keys_str_mv AT kleinnulentthomasjw prostatespecificmembraneantigenpetimagingandimmunohistochemistryinadenoidcysticcarcinomaapreliminaryanalysis
AT vanesrobertjj prostatespecificmembraneantigenpetimagingandimmunohistochemistryinadenoidcysticcarcinomaapreliminaryanalysis
AT krijgergerardc prostatespecificmembraneantigenpetimagingandimmunohistochemistryinadenoidcysticcarcinomaapreliminaryanalysis
AT debreeremco prostatespecificmembraneantigenpetimagingandimmunohistochemistryinadenoidcysticcarcinomaapreliminaryanalysis
AT willemsstefanm prostatespecificmembraneantigenpetimagingandimmunohistochemistryinadenoidcysticcarcinomaapreliminaryanalysis
AT dekeizerbart prostatespecificmembraneantigenpetimagingandimmunohistochemistryinadenoidcysticcarcinomaapreliminaryanalysis